BioLineRx(BLRX)

0.8500 -0.0216 -2.4785%

今开:0.8734昨收:0.871603
最高:0.89 最低:0.813
涨停价:0.0跌停价:0.0
总市值:6.7948385E7

BioLineRx的热门讨论

财报披露

BioLineRx(BLRX)05-06 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001582  Act: 34  Size: 607 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-28 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001842  Act: 34  Size: 1 MB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-24 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001827  Act: 34  Size: 599 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-18 05:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001769  Act: 34  Size: 588 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-30 19:25

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001889  Act: 34  Size: 595 KB 网页链接查看全文

BioLineRx的最新讨论

忘江2018-10-19 23:10

$BioLineRx Ltd. - American Depositary Shares(BLRX)$
BioLineRx (BLRX -21%) is down out of the gate this morning as investors appear disappointed with topline results from a Phase 2a clinical trial evaluating lead candidate BL-8040 plus Merck's (MRK -0.1%) Keytruda...查看全文

忘江2018-10-19 23:00

$BioLineRx Ltd. - American Depositary Shares(BLRX)$
看来赌数据真是不能赌啊。
下面摘自半年报。
Expected significant milestones in next 18 months:
Top-line results in immuno-oncology Phase 2a COMBAT study in pancreatic cancer for BL-8040 in combination with KEY...查看全文

梦里逆天的喵2018-10-10 22:18

$BioLineRx Ltd. - American Depositary Shares(BLRX)$ 天啊,难道要靠织布机逆袭查看全文

梦里逆天的喵2018-10-10 00:55

$BioLineRx Ltd. - American Depositary Shares(BLRX)$ 我勒个擦,你是纺织股啊?!查看全文

1 2 3 4 5 6 7 8

BioLineRx的公告

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001889  Act: 34  Size: 595 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001842  Act: 34  Size: 1 MB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001827  Act: 34  Size: 599 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001769  Act: 34  Size: 588 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001582  Act: 34  Size: 607 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001347  Act: 34  Size: 612 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001285  Act: 34  Size: 595 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001174  Act: 34  Size: 1 MB 网页链接

招股说明书

$BioLineRx(BLRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001178913-24-001173  Act: 33  Size: 733 KB 网页链接

年度财报「修正」

$BioLineRx(BLRX)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-24-001095  Act: 34  Size: 14 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40